Tuesday, October 20, 2009: 2:30 PM
Grand Ballroom, Salons 1 & 2 (Renaissance Hollywood Hotel)
* Candidate for the Lee B. Lusted Student Prize Competition
Click on the Individual Presentation Titles to view the abstract details.
Click here to view Poster Number Acronyms
* EFFECT OF MANAGEMENT STRATEGIES AND CLINICAL STATUS ON COSTS OF CARE FOR MULTI-DRUG RESISTANT HIV
Paul G. Barnett, PhD1, Adam Chow1, Vilija R. Joyce, MS1, Ahmed M. Bayoumi, MD, MSc2, Susan C. Griffin, MSc, BSc3, Huiying Sun, PhD4, Mark Holodniy, MD5, Sheldon T. Brown, MD6, D. William Cameron, MD7, Mark Sculpher, PhD3, Mike Youle, MB, ChB8, Aslam H. Anis, PhD9, Gillian D. Sanders, PhD10 and Douglas K. Owens, MD, MS11, (1)VA Palo Alto Health Care System, Menlo Park, CA, (2)Centre for Research on Inner City Health, the Keenan Research Centre in the Li Ka Shing Knowledge Institute, Toronto, ON ON ON, Canada Canada Canada, (3)University of York, York, United Kingdom, (4)St. Paul's Hospital, Vancouver, BC, Canada, (5)VA Palo Alto Health Care System, Palo Alto, CA, (6)Bronx VA Medical Center, Bronx, NY, (7)Ottawa Hospital, Ottawa, ON, Canada, (8)Royal Free Hospital, London, United Kingdom, (9)University of British Columbia, Vancouver, BC, Canada, (10)Duke, Durham, NC, (11)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
* COST-EFFECTIVENESS OF IMPLEMENTING THE CHRONIC CARE MODEL FOR DIABETES CARE IN THE COMMUNITY
Shihchen Kuo, RPh, MSCP1, Kenneth J. Smith, MD, MS2, Janice C. Zgibor, RPh, PhD1, Gretchen A. Piatt, CHES, MPH, PhD3, Mark S. Roberts, MD, MPP2 and Cindy L. Bryce, PhD2, (1)University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, (2)University of Pittsburgh School of Medicine, Pittsburgh, PA, (3)University of Pittsburgh Diabetes Institute, Pittsburgh, PA
* COST-EFFECTIVENESS OF PSYCHOTHERAPY FOR CLUSTER C PERSONALITY DISORDERS
Djøra I. Soeteman, MA, De Viersprong/ Erasmus Medical Center Rotterdam, Halsteren, Netherlands, Roel Verheul, PhD, University of Amsterdam, Amsterdam, Netherlands, Jan J.V. Busschbach, PhD, Erasmus Medical Center, Rotterdam, Netherlands and Jane J. Kim, PhD, Harvard School of Public Health, Boston, MA
* BENEFITS OF AN INTERVENTION TO MANAGE POTENTIAL MISUSE OF NARCOTICS
Karen M. Stockl, PharmD, Jennifer Shin, PharmD, Sherry Gong, MS, Ann S.M. Harada, PhD, MPH, Brian K. Solow, MD, FAAFP and Heidi C. Lew, PharmD, Prescription Solutions, Irvine, CA
* COST-EFFECTIVENESS AND VALUE OF INFORMATION ANALYSIS OF LONG-TERM OUTPATIENT BUPRENORPHINE TREATMENT FOR OPIOID DEPENDENCE: POTENTIAL IMPACT OF GENERIC COMPETITION
Bruce R. Schackman, PhD1, Jared A. Leff, MS1, Brent A. Moore, PhD2 and David A. Fiellin, MD2, (1)Weill Cornell Medical College, New York, NY, (2)Yale University School of Medicine, New Haven, CT
* THE SAFETY AND EFFICACY OF RECOMBINANT ACTIVATED FACTOR VIIA FOR NON-TRAUMATIC INTRACRANIAL HEMORRHAGE: PATTERNS OF USE AND COMPARATIVE EFFECTIVENESS REVIEW
Veronica Yank, MD1, Craig V. Tuohy, BS1, Aaron Logan, MD, PhD2, Dena M. Bravata, MD, MS1, Kristan Staudenmayer, MD1, Robin Eisenhut, BA1, Vandana Sundaram, MPH3, Donal McMahon, MS, MSc1, Ingram Olkin, PhD4, Kathryn M. McDonald, MM1, Douglas K. Owens, MD, MS5 and Randall S. Stafford, MD, PhD2, (1)Stanford University, Stanford, CA, (2)Stanford University School of Medicine, Stanford, CA, (3)VA Palo Alto Health Care System, Palo Alto, CA, (4)Stanford University, Palo Alto, CA, (5)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
* AN EMPIRICAL COST-EFFECTIVENESS ANALYSIS OF NEW CHEMOTHERAPEUTICS FOR COLORECTAL CANCER
David H. Howard, PhD1, John S. Kauh, MD2, Anirban Basu, PhD3 and Joseph Lipscomb, PhD1, (1)Emory University, Atlanta, GA, (2)Emory University School of Medicine, Atlanta, GA, (3)University of Chicago, Chicago, IL
* COST-EFFECTIVE STRATEGIES FOR ISONIAZID-BASED TUBERCULOSIS (TB) PREVENTIVE THERAPY FOR HIV-INFECTED ART-NAÏVE PATIENTS IN SOUTHERN INDIA
Mai T. Pho, MD1, Soumya Swaminathan, MD2, N. Kumarasamy, MBBS, PhD3, Elena Losina, PhD4, Chinnaiyan Ponnuraja, PhD2, Lauren M. Uhler, BA5, Callie A. Scott, MSc5, Kenneth H. Mayer, MD6, Kenneth A. Freedberg, MD, MSc5 and Rochelle P. Walensky, MD, MPH7, (1)Beth Israel Deaconess Medical Center, Boston, MA, (2)Tuberculosis Research Centre, Chennai, India, (3)YRG Centre for AIDS Research and Education, Chennai, India, (4)Brigham and Women's Hospital, Boston, MA, (5)Massachusetts General Hospital, Boston, MA, (6)The Miriam Hospital, Providence, RI, (7)Harvard Medical School, Boston, MA
* EXAMINING THE QUALITY OF DECISIONS ABOUT BREAST RECONSTRUCTION
Clara Lee, MD, MPP1, Jeffrey K. Belkora, PhD2, Yuchiao Chang, PhD3, Carol Cosenza, MSW4, Carrie A. Levin, PhD5, Beverly Moy, MD, MPH3, Ann Partridge, MD, MPH6 and Karen R. Sepucha, PhD3, (1)University of North Carolina Chapel Hill, Chapel Hill, NC, (2)University of California, San Francisco, San Francisco, CA, (3)Massachusetts General Hospital, Boston, MA, (4)University of Massachusetts Boston, Boston, MA, (5)Foundation for Informed Medical Decision Making, Boston, MA, (6)Dana-Farber Cancer Institute, Boston, MA
* TRIAL OF LABOR OR ELECTIVE REPEAT CESAREAN AFTER ONE PRIOR CESAREAN DELIVERY? A COST-UTILITY ANALYSIS
Erica Wu, BAS, Anjali J. Kaimal, MD, MAS and Miriam Kuppermann, PhD, MPH, University of California, San Francisco, San Francisco, CA
* “A COST-EFFECTIVENESS ANALYSIS OF CETUXIMAB PLUS PLATINUM-BASED CHEMOTHERAPY VERSUS PLATINUM-BASED CHEMOTHERAPY ALONE IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: A CANADIAN PERSPECTIVE”
C. Sehgal, MD1, J. Cao, MD2, J. Mocanu, PhD1 and Gregory S. Zaric, PhD1, (1)University of Western Ontario, London, ON, Canada, (2)London Regional Cancer Program, University of Western Ontario, London, ON, Canada
* COST-EFFECTIVENESS OF ELECTIVE INDUCTION OF LABOR AT 40 WEEKS: MATERNAL PREFERENCES MATTER
Anjali Kaimal, MD, MAS1, Kathryn A. Houston, MD, MA2, Erica Wu, BAS2, Miriam Kuppermann, PhD, MPH2 and Aaron B. Caughey, MD, MPP, MPH, PhD2, (1)Massachusetts General Hospital, Harvard Medical School, Boston, MA, (2)University of California, San Francisco, San Francisco, CA
* COMPARATIVE EFFECTIVENESS OF ROSIGLITAZONE (ROSI) AND PIOGLITAZONE (PIO) IN TREATMENT OF TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Nazila Assasi, MD, PhD1, Anne Holbrook, MD, PharmD, MSc, FRCPC2, Gordon Blackhouse, MSc.3, Kaitryn Campbell, BSc.4, Robert Hopkins, MA3, Daria O'Rielly, Msc, PhD3 and Ron Goeree, MA3, (1)St. Joseph's Healthcare/McMaster University, Hamilton, ON, Canada, (2)McMaster University, Hamilton, Ontario, Hamilton, ON, Canada, (3)McMaster University, Hamilton, ON, Canada, (4)PATH Research Institute, Hamilton, ON, Canada
* TRAINING TO IMPROVE DOCTORS' CLINICAL DECISION MAKING: A SYSTEMATIC REVIEW
Leila Mehdizadeh, BSc, Hilary Bekker, PhD, Vikram Jha, MBBS, MRCOG, MMEd, PhD and Naomi Quinton, PhD, University of Leeds, Leeds, United Kingdom
* THE IMPORTANCE OF HISTOLOGY IN EVALUATING THE COST-EFFECTIVENESS OF PEMETREXED MAINTENANCE AFTER FIRST-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
Robert W. Klein, MS1, Catherine E. Muehlenbein, MPH, MBA2, Ronald C. Wielage, MA, MPH1, Astra M. Liepa, PharmD2 and Steve M. Babineaux, MS, RPh2, (1)Medical Decision Modeling, Inc., Indianapolis, IN, (2)Eli Lilly and Company, Indianapolis, IN
* ASSESSING THE RELATIONSHIP BETWEEN ADHERENCE AND HEALTH CARE COSTS: EVIDENCE FROM A MANAGED CARE POPULATION WITH ULCERATIVE COLITIS
Debanjali Mitra, MA, MBA1, Keith L. Davis, MA1, Paul Hodgkins, PhD2, Linnette Yen, MS, MA2, Dory Solomon, MD2 and Russell D. Cohen, MD, FACG, AGAF3, (1)RTI Health Solutions, Research Triangle Park, NC, (2)Shire Pharmaceuticals, Wayne, PA, (3)The University of Chicago Medical Center, Chicago, IL
* ASSOCIATION OF NONCOMPLIANCE WITH CLINICAL TREATMENT GUIDELINES AND DISEASE BURDEN IN A CALIFORNIA MEDICAID CARDIOVASCULAR DISEASE POPULATION
Michael B. Nichol, PhD1, Joanne Wu, MD, MS1, Julie L. Priest, MSPH2, Tara K. Knight, PhD1 and C. Ron Cantrell, Ph.D.2, (1)University of Southern California, Los Angeles, CA, (2)GlaxoSmithKline, Research Triangle Park, NC
* THE IMPACT OF MULTIPLE CADIOVASCULAR MEDICATIONS USE ON MEDICATION ADHERENCE IN A CALIFORNIA MEDICAID POPULATION WITH CARDIOVASCULAR DISEASE
Joanne Wu, MD, MS1, Tara K. Knight, PhD1, Julie L. Priest, MSPH2, C. Ron Cantrell, Ph.D.2 and Michael B. Nichol, PhD1, (1)University of Southern California, Los Angeles, CA, (2)GlaxoSmithKline, Research Triangle Park, NC
* PRELIMINARY COST-EFFECTIVENESS ANALYSIS OF ROTAVIRUS VACCINATION IN NORWAY
Kristian Samdal, MPhil1, Gunhild Hagen, MPhil1, Elmira Flem, MD, MPH2 and Marianne Klemp Gjertsen, MD, PhD3, (1)Norwegian Knowledge Centre for the Health Services, Oslo, Norway, (2)Norwegian Institute of Public Health, Oslo, Norway, (3)University of Oslo, Oslo, Norway
* USING A PICTORIAL BODY SIZE GUIDE TO ASSESS WOMEN'S PERCEPTIONS OF IDEAL BODY SIZE AND ASSOCIATIONS WITH WEIGHT-RELATED HEALTH BELIEFS
Kimberly Bosworth Blake, PharmD, MBA1, Carole V. Harris, PhD2, Andrew S. Bradlyn, PhD2 and Erdogan Gunel, PhD3, (1)West Virginia University School of Pharmacy, Morgantown, WV, (2)West Virginia University School of Medicine, Morgantown, WV, (3)West Virginia University, Morgantown, WV
* THE IMPACT OF A MISMATCH BETWEEN PATIENTS' AND PROVIDERS' REACTIONS TO UNCERTAINTY ON PATIENTS' BREAST HEALTH DECISIONS AND DECISION SATISFACTION
Mary C. Politi, PhD1, Melissa A. Clark, PhD2, Hernando Ombao, PhD2 and France Légaré, MD, PhD3, (1)Miriam Hospital/Alpert Medical School of Brown University, Providence, RI, (2)Brown University, Providence, RI, (3)CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada
* INFORMATION SEEKING BEHAVIOR OF ONCOLOGISTS ON BENEFITS AND HARMS OF CANCER TREATMENTS IN THE CONTEXT OF EVIDENCE-BASED-MEDICINE – A QUALITATIVE STUDY
Ambuj Kumar, MD, MPH, Asmita R. Mhaskar, BHMS, MPH, Benjamin Djulbegovic, MD, PhD, Clement Gwede, PhD, MPH, RN and Gwendolyn P. Quinn, PhD, Moffitt Cancer Center, Tampa, FL
* ICU QUALITY, PROVIDER MORALE, AND PATIENT/RELATIVE SATISFACTION IN TWO HOSPITALS AT THE EXTREMES OF END-OF-LIFE TREATMENT INTENSITY
Courtney L. Sperlazza, MPH1, Judith A. Tate, RN2, Keri L. Rodriguez, PhD3, Robert M. Arnold, MD1 and Amber E. Barnato, MD, MPH, MS1, (1)University of Pittsburgh School of Medicine, Pittsburgh, PA, (2)University of Pittsburgh School of Nursing, Pittsburgh, PA, (3)VA Pittsburgh Healthcare System, Pittsburgh, PA
* PROVIDER AND ORGANIZATIONAL NORMS OF CARE: A STUDY OF TWO HOSPITALS AT THE EXTREMES OF END-OF-LIFE TREATMENT INTENSITY
Amber E. Barnato, MD, MPH, MS1, Judith A. Tate, RN2, Keri L. Rodriguez, PhD3, Courtney L. Sperlazza, MPH1 and Robert M. Arnold, MD1, (1)University of Pittsburgh School of Medicine, Pittsburgh, PA, (2)University of Pittsburgh School of Nursing, Pittsburgh, PA, (3)VA Pittsburgh Healthcare System, Pittsburgh, PA
* CLINICAL REMINDERS DESIGNED AND IMPLEMENTED USING COGNITIVE AND ORGANIZATIONAL SCIENCE PRINCIPLES DO NOT PRODUCE "REMINDER FATIGUE"
Lee Green, MD, MPH, Donald E. Nease, MD, Michael S. Klinkman, MD, MS and Jean M. Malouin, MD, MHSA, University of Michigan, Ann Arbor, MI
* GIRLS' PREFERENCES FOR HPV-VACCINATIONS: A DISCRETE CHOICE EXPERIMENT
Esther W. de Bekker-Grob, MSc, Robine Hofman, MSc, Marjolein van Ballegooijen, MD, PhD, Hein Raat, MD, PhD and Ida J. Korfage, PhD, Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands
* A WEB-BASED APPLICATION OF MULTI-CRITERIA DECISION ANALYSIS MODEL FOR PRIORITISING PREVENTIVE HEALTHCARE OPTIONS
Lyndal Trevena, PhD, The University of Sydney, New South Wales, Australia, Siranda Torvaldsen, PhD, The University of Sydney, University of Sydney, Australia and Jack Dowie, PhD, London School of Hygiene and Tropical Medicine, London, United Kingdom
* A COMPARISON OF DIRECT AND INDIRECT MEASURES OF OPTIMISTIC BIAS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Lucy E. Napper, PhD, Eileen P. Garcia, BA, Dennis G. Fisher, PhD and Grace L. Reynolds, DPA, California State University, Long Beach, Long Beach, CA
* ELICITING PARTICIPANT PREFERENCES IN THE COURSE OF A CLINICAL TRIAL: THE ONGOING SILENT INFARCT TRANSFUSION (SIT) STUDY IN SICKLE CELL DISEASE
Harold Lehmann1, Michael R. Debaun, MD, MPH2, Julie Panepinto, MD, MSPH3, James F. Casella, MD4, Bruce Barton, PhD5, Fred Prior, PhD2, Robert C. McKinstry III, MD, PhD2, Desiree White, PhD2, Michael J. Noetzel, MD2 and Rebecca N. Ichord, MD6, (1)Johns Hopkins University, Baltimore, MD, (2)Washington University School of Medicine, St Louis, MO, (3)Medical College of Wisconsin, Milwaukee, WI, (4)Johns Hopkins, Baltimore, MD, (5)Maryland Medical Research Institute, Baltimore, MD, (6)Children's Hospital of Philadelphia, Philadelphia, PA
* AMNIOCENETISIS BASED ON THE POTENTIAL FOR SIGNIFICANT CHROMOSOMAL ABNORMALITIES: A DECISION ANALYSIS
Brian Shaffer, MD1, Susan Tran, MD2, Mary Norton, MD2, Kati Malabed, MS3, Sherri Pena, MS3 and Aaron B. Caughey, MD, MPP, MPH, PhD4, (1)University of California, San Francisco, CA, (2)Kaiser Permanente Medical Center, San Francisco, CA, (3)UCSF, San Francisco, CA, (4)University of California, San Francisco, San Francisco, CA
* PREDICTING EUROQOL EQ-5D UTILITY SCORES FROM THE SEATTLE ANGINA QUESTIONNAIRE IN CORONARY ARTERY DISEASE: A MAPPING ALGORITHM USING A BAYESIAN FRAMEWORK
Harindra C. Wijeysundera, MD1, George Tomlinson, PhD2, Colleen M. Norris, PhD3, William A. Ghali, MD, MPH4, Dennis T. Ko, MD, MSc5 and Murray D. Krahn, MD, MSc2, (1)Schulich Heart Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada, (2)University of Toronto, Toronto, ON, Canada, (3)University of Alberta, Edmonton, AB, Canada, (4)University of Calgary, Calgary, AB, Canada, (5)Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
* PATIENT PREFERENCES FOR DIFFERENT SEVERITIES OF AND TREATMENTS FOR URGE URINARY INCONTINENCE
Jennifer M. Wu, MD, MPH1, R. Grace Fulton, BS1, Cindy L. Amundsen, MD1, Sharon K. Knight, MD2 and Miriam Kuppermann, PhD, MPH2, (1)Duke University, Durham, NC, (2)University of California, San Francisco, San Francisco, CA
* THE IMPACT OF HEALTH STATE “FEASIBILITY” ON THE ESTIMATION OF VALUES FOR EQ-5D
Ling-Hsiang Chuang, MSc1, Paul Kind1, Victor Zarate, MD, MSc1 and Hae-Sung Nam, MD2, (1)University of York, York, United Kingdom, (2)University of Korean, Daejeon, South Korea
* METHODS OF TIME PREFERENCE EVALUATION FOR FUTURE HEALTH STATES
Ashley E. Levack, BA, MAS1, Daniel S. Schatzle, BS1 and Theodore G. Ganiats, MD2, (1)University of California, San Diego, San Diego, CA, (2)UCSD School of Medicine, La Jolla, CA
* ISHOULD: DEVELOPMENT AND PILOT TESTING OF THE OTTAWA PERSONAL DECISION GUIDE FOR USE ON THE FACEBOOK SOCIAL NETWORKING PLATFORM
Anton Saarimaki, MCS1, Elizabeth Drake, MHA1 and Annette M. O'Connor, PhD2, (1)Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)University of Ottawa, Ottawa, ON, Canada
* WEB-BASED PREDICTION MODEL DEPLOYMENT APPLICATION
Michael W. Kattan, PhD1, Changhong Yu, MS1, Brian J. Wells, MD, MS1 and C. Greg Hagerty, PhD2, (1)Cleveland Clinic, Cleveland, OH, (2)University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, New Brunswick, NJ
* DESIGNING A SIMPLE DECISION AID FOR A SCHOOL-BASED HPV VACCINE PROGRAM
Carol Bennett, MSc1, Elizabeth Drake, MHA1, Laura Hopkins, BSc, MSc, MD2, Sara D. Khangura, BA1, Debra Morris1, Anton Saarimaki, MCS1 and Annette M. O'Connor, PhD2, (1)Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)University of Ottawa, Ottawa, ON, Canada
* A NATIONALLY REPRESENTATIVE AMBULATORY ELECTRONIC HEALTH RECORD SYSTEM FOR CLINICAL OUTCOMES RESEARCH: THE MEDICAL QUALITY IMPROVEMENT CONSORTIUM (MQIC)
Michael Lieberman, MD, MS1, Erica Danielson, PhD, MBA1, Lee Kallenbach, PhD, MPH2 and Teresa Zyczynski, PharmD, MBA, MPH3, (1)GE Healthcare Information Technology, Hillsboro, OR, (2)Clinical Data Services, GE Healthcare, Plano, TX, (3)Clinical Data Services, GE HealthCare, Princeton, NJ
* APPLYING COMPARATIVE EFFECTIVENESS EVIDENCE TO A PREFERENCE-BASED DECISION AID ON TREATMENTS FOR LOCALIZED PROSTATE CANCER
David H. Hickam, MD, MPH1, Karen B. Eden, PhD1, Poonam Singh Sharma, MS1, Seth E. Meyer, MA1, Susan Severance, MPH1 and Anais Tuepker, PhD2, (1)Oregon Health and Science University, Portland, OR, (2)Portland VA Medical Center, Portland, OR
* DECISION AID FOR ANTIPSYCHOTIC MEDICATION CHOICE
Lisa A. Mistler, MD, MS, University of Massachusetts, Worcester, MA, Laurie A. Curtis, Advocates for Human Potential Inc., Middlesex, VT and Irma H. Mahone, University of Virginia, Charlottesville, VA
* ANALYSING CLINICAL TRIAL DATA TO PROVIDE INPUTS TO DECISION MODELS
Susan C. Griffin, MSc, BSc1, Ahmed M. Bayoumi, MD, MSc2, Douglas K. Owens, MD, MS3, Huiying Sun, PhD4, Paul G. Barnett, PhD5, Gillian D. Sanders, PhD6, Aslam H. Anis, PhD7, Mark Holodniy, MD8, Sheldon T. Brown, MD9, D. William Cameron, MD10 and Mark Sculpher, PhD1, (1)University of York, York, United Kingdom, (2)Centre for Research on Inner City Health, the Keenan Research Centre in the Li Ka Shing Knowledge Institute, Toronto, ON ON ON, Canada Canada Canada, (3)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (4)St. Paul's Hospital, Vancouver, BC, Canada, (5)VA Palo Alto Health Care System, Menlo Park, CA, (6)Duke, Durham, NC, (7)University of British Columbia, Vancouver, BC, Canada, (8)VA Palo Alto Health Care System, Palo Alto, CA, (9)Bronx VA Medical Center, Bronx, NY, (10)Ottawa Hospital, Ottawa, ON, Canada
* TWO VAGUE PRIORS FOR BAYESIAN BIVARIATE BINOMIAL MODELS FOR META-ANALYSIS OF DIAGNOSTIC TESTS: A SIMULATION STUDY
Yan Xing, MD, MS, PhD1, Janice N. Cormier, MD, MPH1, Asha S. Kapadia, PhD2, John M. Swint, PhD2 and Claudia Pedroza, PhD3, (1)The University of Texas M.D. Anderson Cancer Center, Houston, TX, (2)The University of Texas School of Public Health, Houston, TX, (3)UT Medical School at Houston, Houston, TX
* ADDRESSING DECISIONS ABOUT CLINICAL GUIDANCE AND IMPLEMENTATION STRATEGIES – A SEQUENTIAL OR AN INTEGRAL APPROACH? AN APPLICATION RELATING TO METASTATIC HORMONE-REFRACTORY PROSTATE CANCER
Ties Hoomans, PhD, Maastricht University / University of Glasgow, Maastricht, Netherlands, Hans Severens, PhD, Maastricht University / Academic Hospital Maastricht, Maastricht, Netherlands, Andre Ament, PhD, Maastricht University, Maastricht, Netherlands and Elisabeth A.L. Fenwick, PhD, University of Glasgow, Glasgow, United Kingdom
